Researcher
Philip Van Damme
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Philip Van Damme (Flanders Institute for Biotechnology)
Affiliations
- Van Den Bosch Lab (Research group)
Member
From1 Jan 2017 → Today - Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 2000 → 31 Dec 2011
Projects
1 - 10 of 49
- Towards mechanistic biomarkers for amyotrophic lateral sclerosisFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mapping the microglial heterogeneity in C9orf72-ALS and sporadic ALS using single cell profilingFrom1 Nov 2023 → TodayFunding: BOF - postdoctoral mandates
- A multi-modal and longitudinal approach to study the neurobiological underpinnings of disease onset and progression in genetic ALS variants: from presymptomatic to symptomatic disease stages.From1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutationsFrom19 Apr 2023 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- Measuring brain activation non-invasively in freely moving healthy and neuropsychiatric human populations using functional near-infrared spectroscopy (fNIRS)From1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Investigating the role of cilia dysfunction in Amyotrophic Lateral SclerosisFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mechanisms of motor neuron degeneration in amyotrophic lateral sclerosis (ALS): cell death pathways and/or aberrant communication between cell body and neuromuscular junctionsFrom1 Oct 2022 → TodayFunding: BOF - projects
- A multi-modal approach to study C9orf72-mediated diseaseFrom16 May 2022 → 15 May 2023Funding: BOF - postdoctoral mandates
- Biomarkers in asymptomatic carriers of ALS-related mutationsFrom1 Apr 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Understanding lysosomal dysfunction in the frontotemporal dementiaamyotrophic lateral sclerosis spectrum of neurodegenerative disorders.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 341
- HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS(2022)
Authors: Elke Braems, Valérie Bercier, Evelien Van Schoor, Kara Heeren, Jimmy Beckers, Ilse Geudens, Dietmar Thal, Philip Van Damme, Bart Swinnen, Ludo Van Den Bosch
Pages: 465 - 488 - Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex(2022)
Authors: Evelien Van Schoor, Sandra Oliveira Tomé, Philip Van Damme, Ludo Van Den Bosch, Dietmar Thal
Pages: 393 - 411 - Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease(2022)
Authors: Philip Van Damme
Pages: E536 - E548 - Characterising ALS disease progression according to El Escorial and Gold Coast criteria(2022)
Authors: Pegah Masrori, Philip Van Damme
Pages: 865 - 870 - Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72(2022)
Authors: Mathieu Vandenbulcke, Philip Van Damme, Paul Suetens, Patrick Dupont, Peter Claes, Rik Vandenberghe
- PMP22 OVEREXPRESSION CAUSES LIPID RECYCLING DEFECTS THAT ALTERS THE PLASMA MEMBRANE IN CMT1A(2022)
Authors: Robert Ciarán Prior, Vincent de Laat, Jonas Dehairs, Philip Van Damme, Johan Swinnen, Ludo Van Den Bosch
Pages: S108 - S108 - Neuromuscular complications after COVID-19 vaccination: a series of eight patients(2022)
Authors: Robin Lemmens, Philip Van Damme
Pages: 753 - 761 - Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis.(2022)
Authors: Pegah Masrori, Maxim De Schaepdryver, Joke De Vocht, Koen Poesen, Philip Van Damme
Pages: 1 - 2 - HDAC3 Inhibition Stimulates Myelination in a CMT1A Mouse Model(2022)
Authors: Robert Ciarán Prior, Elisabeth Rossaert, Alessio Silva, Philip Van Damme, Ludo Van Den Bosch
Pages: 3414 - 3430 - The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis(2022)
Authors: Philip Van Damme
Pages: 1207 - 1210